YB3.F Shin Nippon Biomedical Laboratories Ltd

Healthcare Biotechnology Frankfurt Exchange
6.85 EUR
Close of Nov 12, 2026
5.61 10.50
Market cap
EUR 285M
P/E
9.1x
P/B
1.25x
ROE
11.1%
Dividend yield
4.00%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Sep 2026.

Is YB3.F undervalued?

Graham number
Price6.85
Graham value9.60
Discount28.7%

YB3.F trades 28.7% below its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Shin Nippon Biomedical Laboratories Ltd fundamental analysis

No fundamental analysis for Shin Nippon Biomedical Laboratories Ltd yet.

Shin Nippon Biomedical Laboratories Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Shin Nippon Biomedical Laboratories Ltd

Shin Nippon Biomedical Laboratories, Ltd., a contract research organization, engages in the pharmaceutical development, transactional research, and medipolis businesses in Japan and internationally. It offers non-clinical testing and non-clinical regulatory consulting for the development of pharmaceuticals, medical devices, or regenerative medicine products, including safety and pharmacology testing, and pharmacokinetic studies. The company also engages in licensing activiti…

Full company profile